Literature DB >> 15849753

2-5A induces a conformational change in the ankyrin-repeat domain of RNase L.

Masayuki Nakanishi1, Yoshikuni Goto, Yukio Kitade.   

Abstract

RNase L is responsible for the 2-5A host defense system, an RNA degradation pathway present in cells of higher vertebrates that functions in both the antiviral and anticellular activities of interferon. The activity of RNase L is tightly regulated and is exerted only in the presence of 2-5A. The postulated mechanism of its regulation is as follows: the N-terminal half ankyrin-repeat domain masks the C-terminal half nuclease domain in the absence of 2-5A. On binding 2-5A at the ankyrin-repeat domain, RNase L forms a homodimer and removes the ankyrin-repeat domain from the nuclease domain to become the active form. A conformational change in the ankyrin-repeat domain is a key step in this hypothetical mechanism, but there is as yet no evidence for such a change. To clarify the events induced by 2-5A binding, we established procedures for expression and purification of the ankyrin-repeat domain of human RNase L. Fluorescence spectra of the protein showed clear difference in the presence and absence of 2-5A. The alterations in the spectra supported conformational changes of the protein. Time-resolved anisotropy measurements indicated that 2-5A binding led to a significant decrease in the rotational radius of the protein. In addition, 2-5A provided the domain with resistance to protease digestion as a result of a conformational change. These results indicated that the ankyrin-repeat domain of RNase L constricts its structure by binding of 2-5A. This observation suggests a revised model of the 2-5A-induced activation of RNase L.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15849753     DOI: 10.1002/prot.20474

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  11 in total

1.  Inhibition of RNase L and RNA-dependent protein kinase (PKR) by sunitinib impairs antiviral innate immunity.

Authors:  Babal Kant Jha; Irina Polyakova; Patricia Kessler; Beihua Dong; Benjamin Dickerman; Ganes C Sen; Robert H Silverman
Journal:  J Biol Chem       Date:  2011-06-02       Impact factor: 5.157

2.  Turning enzymes ON with small molecules.

Authors:  Julie A Zorn; James A Wells
Journal:  Nat Chem Biol       Date:  2010-03       Impact factor: 15.040

Review 3.  Diverse functions of RNase L and implications in pathology.

Authors:  Catherine Bisbal; Robert H Silverman
Journal:  Biochimie       Date:  2007-02-20       Impact factor: 4.079

4.  Expression, purification and characterization of the interferon-inducible, antiviral and tumour-suppressor protein, human RNase L.

Authors:  Ankush Gupta; Pramod C Rath
Journal:  J Biosci       Date:  2012-03       Impact factor: 1.826

5.  Evasion of antiviral innate immunity by Theiler's virus L* protein through direct inhibition of RNase L.

Authors:  Frédéric Sorgeloos; Babal Kant Jha; Robert H Silverman; Thomas Michiels
Journal:  PLoS Pathog       Date:  2013-06-27       Impact factor: 6.823

6.  Curcumin, a natural antioxidant, acts as a noncompetitive inhibitor of human RNase L in presence of its cofactor 2-5A in vitro.

Authors:  Ankush Gupta; Pramod C Rath
Journal:  Biomed Res Int       Date:  2014-09-02       Impact factor: 3.411

7.  A novel mechanism of RNase L inhibition: Theiler's virus L* protein prevents 2-5A from binding to RNase L.

Authors:  Melissa Drappier; Babal Kant Jha; Sasha Stone; Ruth Elliott; Rong Zhang; Didier Vertommen; Susan R Weiss; Robert H Silverman; Thomas Michiels
Journal:  PLoS Pathog       Date:  2018-04-13       Impact factor: 6.823

8.  Characterization of the equine 2'-5' oligoadenylate synthetase 1 (OAS1) and ribonuclease L (RNASEL) innate immunity genes.

Authors:  Jonathan J Rios; Andrey A Perelygin; Maureen T Long; Teri L Lear; Andrey A Zharkikh; Margo A Brinton; David L Adelson
Journal:  BMC Genomics       Date:  2007-09-07       Impact factor: 3.969

Review 9.  Interferon-inducible antiviral effectors.

Authors:  Anthony J Sadler; Bryan R G Williams
Journal:  Nat Rev Immunol       Date:  2008-07       Impact factor: 53.106

Review 10.  Can't RIDD off viruses.

Authors:  Sankar Bhattacharyya
Journal:  Front Microbiol       Date:  2014-06-18       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.